Lenalidomide Capsules

  • Product Name : Lenalidomide Capsules
  • Trade Name : Lenalid, Revlimid
  • Available Strength : 5 mg, 10 mg, 25 mg
  • Packing : 10X10 Capsules/Box
  • Pack Insert/Leaflet : Yes
  • Therapeutic use : Anti Cancer
  • Production Capacity : 1 million capsule/month
Request A Quote


What is Lenalidomide?
Lenalidomide Capsule is a medicine that is used for the treatment of Immature Blood Cells Cancer, White Blood Cell Cancer, Hodgkin’S Lymphoma, Non Hodgkin’S Lymphoma, Blood Cancer, Bone Marrow Cancer and other conditions.
Lenalidomide Capsule contains Linalidomide as an active ingredient.
Lenalidomide Capsule works by slowing the growth of cancer cells.
Detailed information related to Lenalidomide Capsule’s uses, composition, dosage, side effects and reviews is listed below.

Lenalidomide Capsule Uses
Lenalidomide Capsule is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:

  • Immature Blood Cells Cancer
  • White Blood Cell Cancer
  • Hodgkin’S Lymphoma
  • Non Hodgkin’S Lymphoma
  • Blood Cancer
  • Bone Marrow Cancer

Lenalidomide Capsule Working, Mechanism of Action and Pharmacology
Lenalidomide Capsule improves the patient’s condition by performing the following functions:

  • Slowing the growth of cancer cells.

Lenalidomide Capsule – Composition and Active Ingredients
Lenalidomide Capsule is composed of the following active ingredients (salts)

  • Linalidomide (10 MG)

Please note that this medicine may be available in various strengths for each active ingredient listed above.

Lenalidomide Capsule – Side-effects
The following is a list of possible side-effects that may occur from all constituting ingredients of Lenalidomide Capsule. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.

  • Thromboembolic Disorders
  • Pulmonary Embolism
  • Hepatotoxicity
  • Myelosuppression

Additional Information

The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:

ASIA: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth.

AFRICA: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , and so forth.

NORTH & SOUTH AMERICA: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, and so forth .

EUROPE: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.

OCEANIA: Australia, New Zealand, Fiji, and so forth.